These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17562623)

  • 1. Successful reduced-intensity stem cell transplantation with cord blood for a poor-prognosis adult with refractory chronic active epstein-barr virus infection.
    Nakagawa M; Hashino S; Takahata M; Kawamura T; Fujisawa F; Kahata K; Kondo T; Imamura M; Ando S; Asaka M;
    Int J Hematol; 2007 Jun; 85(5):443-5. PubMed ID: 17562623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr virus infection.
    Iguchi A; Kobayashi R; Sato TZ; Nakajima M; Kaneda M; Ariga T
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):254-6. PubMed ID: 16679925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful umbilical cord blood transplantation for severe chronic active Epstein-Barr virus infection after the double failure of hematopoietic stem cell transplantation.
    Ishimura M; Ohga S; Nomura A; Toubo T; Morihana E; Saito Y; Nishio H; Ide M; Takada H; Hara T
    Am J Hematol; 2005 Nov; 80(3):207-12. PubMed ID: 16247742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic active Epstein-Barr virus infection with marked pericardial effusion successfully treated with allogeneic peripheral blood stem cell transplantation].
    Matsui S; Takeda Y; Isshiki Y; Yamazaki A; Nakao S; Takaishi K; Nagao Y; Hasegawa N; Togasaki E; Shimizu R; Kawajiri C; Sakai S; Mimura N; Takeuchi M; Ohwada C; Sakaida E; Iseki T; Imadome K; Nakaseko C
    Rinsho Ketsueki; 2016 May; 57(5):624-9. PubMed ID: 27263789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
    Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
    Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection.
    Kawa K; Sawada A; Sato M; Okamura T; Sakata N; Kondo O; Kimoto T; Yamada K; Tokimasa S; Yasui M; Inoue M
    Bone Marrow Transplant; 2011 Jan; 46(1):77-83. PubMed ID: 20498651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].
    Sakata N; Sato E; Sawada A; Yasui M; Inoue M; Kawa K
    Rinsho Ketsueki; 2004 May; 45(5):393-6. PubMed ID: 15199749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic active Epstein-Barr virus infection with multiple vascular lesions successfully treated by cord blood transplantation].
    Abe R; Kato J; Hashida R; Yamane Y; Koda Y; Kikuchi T; Shimizu T; Kohno T; Kawano F; Imadome KI; Inoue M; Sasaki A; Kameyama K; Mori T
    Rinsho Ketsueki; 2020; 61(10):1502-1507. PubMed ID: 33162448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hematopoietic cell transplantation for chronic active EBV infection].
    Inoue M
    Rinsho Ketsueki; 2019; 60(9):1331-1336. PubMed ID: 31597860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.
    Watanabe Y; Sasahara Y; Satoh M; Looi CY; Katayama S; Suzuki T; Suzuki N; Ouchi M; Horino S; Moriya K; Nanjyo Y; Onuma M; Kitazawa H; Irie M; Niizuma H; Uchiyama T; Rikiishi T; Kumaki S; Minegishi M; Wada T; Yachie A; Tsuchiya S; Kure S
    Eur J Haematol; 2013 Sep; 91(3):242-248. PubMed ID: 23734904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic peripheral blood stem cell transplantation for the treatment of chronic active Epstein-Barr virus infection.
    Fujii N; Takenaka K; Hiraki A; Maeda Y; Ikeda K; Shinagawa K; Ashiba A; Munemasa M; Sunami K; Hiramatsu Y; Ishimaru F; Niiya K; Yoshino T; Harada M
    Bone Marrow Transplant; 2000 Oct; 26(7):805-8. PubMed ID: 11042666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases.
    Sawada A; Inoue M; Koyama-Sato M; Kondo O; Yamada K; Shimizu M; Isaka K; Kimoto T; Kikuchi H; Tokimasa S; Yasui M; Kawa K
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):214-21. PubMed ID: 24188918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord Blood Transplantation Following Reduced-Intensity Conditioning for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis during Systemic Lupus Erythematosus Treatment.
    Kuriyama T; Kawano N; Yamashita K; Kikuchi I
    J Clin Exp Hematop; 2016; 56(2):126-129. PubMed ID: 27980302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Cord Blood Stem Cell Transplantation for an Adult Case of Chronic Active Epstein-Barr Virus Infection.
    Saburi M; Ogata M; Satou T; Yoshida N; Nagamatsu K; Nashimoto Y; Moroga Y; Takano K; Kohno K; Shirao K
    Intern Med; 2016; 55(23):3499-3504. PubMed ID: 27904117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.
    Roliński J; Grywalska E; Pyzik A; Dzik M; Opoka-Winiarska V; Surdacka A; Maj M; Burdan F; Pirożyński M; Grabarczyk P; Starosławska E
    BMC Infect Dis; 2018 Apr; 18(1):190. PubMed ID: 29678144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ovum collection following ovarian stimulation in patients with chronic active Epstein-Barr virus infection].
    Onozawa E; Ishikawa T; Tomaru Y; Shimizu N; Arai A
    Rinsho Ketsueki; 2018; 59(5):475-479. PubMed ID: 29877232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed death 1 monoclonal antibody helped to treat mixed chimeric and reactivation of Epstein-Barr virus in a patient with adult-onset chronic active Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation: A case report.
    You Y; Wang J; Wang Z
    Medicine (Baltimore); 2022 Jan; 101(2):e28542. PubMed ID: 35029211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of a long-time survivor with chronic active Epstein-Barr virus infection.
    Takeoka Y; Nakao Y; Ueda M; Koh KR; Aoyama Y; Nakamae H; Yamamura R; Ohta K; Takubo T; Yamane T; Hino M; Tokura Y; Ishihara S; Oshima K; Kimura H; Imashuku S
    Eur J Haematol; 2004 Jan; 72(1):73-6. PubMed ID: 14962269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic active Epstein-Barr virus infection with mosquito allergy successfully treated with reduced-intensity unrelated allogeneic bone marrow transplantation in a boy.
    Matsunaga T; Kurosawa H; Okuya M; Nakajima D; Hagisawa S; Sato Y; Fukushima K; Sugita K; Arisaka O
    Pediatr Transplant; 2009 Mar; 13(2):231-4. PubMed ID: 18627511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.